1. CXCR2 inhibition overcomes ponatinib intolerance by eradicating chronic myeloid leukemic stem cells through PI3K/Akt/mTOR and dipeptidylpeptidase Ⅳ (CD26)
   Ji-Hea Kim et al, 2023, Heliyon CrossRef
2. MicroRNAs regulating SOX2 in cancer progression and therapy response
   Sepideh Mirzaei et al, 2021, Expert Reviews in Molecular Medicine CrossRef
3. Dissecting SOX2 expression and function reveals an association with multiple signaling pathways during embryonic development and in cancer progression
   null Niharika et al, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef